Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.

[1]  J. Brown,et al.  Clinical trials of radiosensitizers: what should we expect? , 1984, International journal of radiation oncology, biology, physics.

[2]  N. J. McNally,et al.  The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse. , 1983, British Journal of Cancer.

[3]  N. J. McNally,et al.  Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole. , 1983, British Journal of Cancer.

[4]  J. Brown,et al.  Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole. , 1983, Cancer research.

[5]  P. Workman,et al.  Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. , 1983, British Journal of Cancer.

[6]  D. M. Brown,et al.  Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro. , 1983, Radiation research.

[7]  D. Hirst,et al.  Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. , 1982, British Journal of Cancer.

[8]  D. Hirst,et al.  Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents. , 1982, British Journal of Cancer.

[9]  D. Hirst,et al.  The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity. , 1982, International journal of radiation oncology, biology, physics.

[10]  T. McNeill,et al.  Nitroimidazole neurotoxicity: are mouse studies predictive? , 1982, International journal of radiation oncology, biology, physics.

[11]  P. Workman,et al.  Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships. , 1982, International journal of radiation oncology, biology, physics.

[12]  D. Siemann.  Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers. , 1982, British Journal of Cancer.

[13]  D. Hirst,et al.  Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide. , 1981, British Journal of Cancer.

[14]  S. Zamvil,et al.  Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages. , 1980, Journal of the National Cancer Institute.

[15]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[16]  M. Meistrich,et al.  Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. , 1979, Cancer research.

[17]  P. Band,et al.  Radiation and high-dose metronidazole in supratentorial glioblastomas. , 1976, The New England journal of medicine.

[18]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.